創益通(300991.SZ):擬向商業銀行等金融機構申請綜合授信額度12億元
格隆匯4月5日丨創益通(300991.SZ)公佈,為補充流動資金,滿足公司的發展和生產經營需要,擴大生產規模、提升公司業績,公司及子公司擬向商業銀行等金融機構申請綜合授信額度12億元,融資方式包括但不限於銀行流動資金貸款、固定資產項目貸款、保函、信用證、承兑匯票、票據貼現、保理等。授信業務品種和具體授信額度以公司及子公司與相關銀行最終簽訂的協議為準。
同時,提請股東大會授權公司法定代表人或法定代表人指定的授權代理人在上述授信額度內全權辦理信貸所需事宜並簽署相關合同及文件(包括但不限於授信、借款、擔保、抵押、融資等有關的申請書、合同、協議等文件)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.